Arora Sameer, Matsushita Kunihiro, Qamar Arman, Stacey R Brandon, Caughey Melissa C
Division of Cardiology, University of North Carolina at Chapel Hill, North Carolina.
Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.
Catheter Cardiovasc Interv. 2018 Feb 1;91(2):253-259. doi: 10.1002/ccd.27156. Epub 2017 Jun 1.
Current guidelines recommend early invasive intervention (<24 hr) for high risk patients with non-ST-segment elevation myocardial infarction (NSTEMI). A delayed invasive strategy (24-72 hr) is considered reasonable for low risk patients. The real-world effectiveness of this strategy is unknown.
The ARIC Study has conducted hospital surveillance of acute myocardial infarction (MI) since 1987. NSTEMI was classified using a validated algorithm. We limited our study to patients undergoing early (<24 hr of the event onset), or late (≥24 hr) percutaneous coronary intervention (PCI). Patients were stratified into low (TIMI score 2-4), and high risk (TIMI score 5-7, or presence of cardiogenic shock, ventricular fibrillation, or cardiac arrest). Associations between early versus late PCI and mortality were analyzed using multivariable logistic regression adjusted for demographics, hospitalization year, TIMI score, and comorbidities.
From 1987 to 2012, 6,746 patients were hospitalized with NSTEMI and underwent PCI. Most were white (79%), male (68%), with mean age 61 years. The 28-day and 1-year mortality were 2% and 5%, respectively. Most revascularizations (65%) were late. After accounting for potential confounders, early PCI was associated with a 58% reduced 28-day mortality (OR = 0.42; 95% CI: 0.21-0.84) for the entire population, and 57% reduced mortality (OR = 0.43; 95% CI: 0.21-0.88) for high risk patients. By 1-year of follow up, there was no significant difference in mortality with respect to early vs. late PCI.
In hospitalized NSTEMI patients with high risk of clinical events, early PCI is associated with improved 28-day survival.
当前指南推荐对非ST段抬高型心肌梗死(NSTEMI)高危患者进行早期侵入性干预(<24小时)。对于低危患者,延迟侵入性策略(24 - 72小时)被认为是合理的。该策略在现实世界中的有效性尚不清楚。
自1987年以来,ARIC研究对急性心肌梗死(MI)进行了医院监测。NSTEMI采用经过验证的算法进行分类。我们将研究局限于接受早期(事件发作<24小时)或晚期(≥24小时)经皮冠状动脉介入治疗(PCI)的患者。患者被分为低危(TIMI评分2 - 4)和高危(TIMI评分5 - 7,或存在心源性休克、室颤或心脏骤停)。使用多变量逻辑回归分析早期与晚期PCI和死亡率之间的关联,并对人口统计学、住院年份、TIMI评分和合并症进行了调整。
1987年至2012年,6746例NSTEMI患者住院并接受了PCI。大多数为白人(79%),男性(68%),平均年龄61岁。28天和1年死亡率分别为2%和5%。大多数血运重建(65%)为晚期。在考虑潜在混杂因素后,早期PCI与整个人群28天死亡率降低58%(OR = 0.42;95% CI: 0.21 - 0.84)相关,与高危患者死亡率降低57%(OR = 0.43;95% CI:0.21 - 0.88)相关。到随访1年时,早期与晚期PCI的死亡率无显著差异。
在临床事件高危的住院NSTEMI患者中,早期PCI与28天生存率提高相关。